Professional Bio
Dr. Phillips is a national leader in the treatment of hematologic malignancies and is an innovator in bringing transplant modalities to lymphoma. He is a graduate of the University of Oklahoma School of Medicine where he completed his internship in internal medicine. He continued his residency training at the University of North Carlina School of Medicine and trained at Washington University School of Medicine with a clinical and research fellowship in hematology/oncology. He previously directed the transplant programs at the University of Maryland, University of Kentucky, theUniversity of British Columbia, and Barnes Hospital at the Washington University School of Medicine. Dr. Phillips was the principal investigator of the National Cancer Institute (NCI) study "Improving the Ability of (High-Risk) Hematologic Malignancy Patients to Undergo Allogenic Stem Cell Transplantation".
Dr. Phillips is a member of several editorial boards and has authored and/or co-authored over 200 publications. His research interests include nonmyeloablative (min-dose) transplants and 'alternative donors' for allogenic transplants. He has developed several innovative clinical trials related to stem cell transplantation and is particularly interested in lymphoma, leukemia, and multiple myeloma.
Research Bio
Dr. Phillips is a national leader in the treatment of hematologic malignancies and is an innovator in bringing transplant modalities to lymphoma. He is a graduate of the University of Oklahoma School of Medicine where he completed his internship in internal medicine. He continued his residency training at the University of North Carlina School of Medicine and trained at Washington University School of Medicine with a clinical and research fellowship in hematology/oncology. He previously directed the transplant programs at the University of Maryland, University of Kentucky, theUniversity of British Columbia, and Barnes Hospital at the Washington University School of Medicine. Dr. Phillips was the principal investigator of the National Cancer Institute (NCI) study "Improving the Ability of (High-Risk) Hematologic Malignancy Patients to Undergo Allogenic Stem Cell Transplantation".
Dr. Phillips is a member of several editorial boards and has authored and/or co-authored over 200 publications. His research interests include nonmyeloablative (min-dose) transplants and 'alternative donors' for allogenic transplants. He has developed several innovative clinical trials related to stem cell transplantation and is particularly interested in lymphoma, leukemia, and multiple myeloma.
| Fellowship, American College of Physicians/American Society of Internal Medicine |
1999 |
| Bringing Clinical Renown to Vancouver General Hospital", Vancouver General Hospital Academic Awards Day |
1989 |
| Outstanding Teacher, Washington University School of Medicine |
1980 |
| American Board of Medical Oncology |
1979 |
| American Cancer Society Junior Faculty Award (renewed 1979 and 1980) |
1978 |
| American Board of Internal Medicine |
1974 |
| Outstanding Resident in Medicine, University of North Carolina School of Medicine |
1974 |
| Physiology Award, University of Oklahoma School of Medicine |
1972 |
2012
Biswas, T; Culakova, E; Friedberg JW; Kelly, JL; Dhakal, S; Liesveld, J; Phillips GL; Constine LS. "Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma". Radiotherapy and Oncology. 2012; 103: 367-372. |
2011
Phillips, GL; Bernstein, S; Liesveld, JL; Abboud, CN; Becker, MW; Constine, LS; Ifthikharuddin, JJ; Loughner, JE; Milner, LA; Vesole, DH. "A Phase I Trial Dose Escalation in the "BEAM" Regimen Using Amifostine Cytoprotection". Biology of Blood and Marrow Transplantation. 2011; 17(7): 1033-42. |
2011
Keller, SF; Kelly, JL; Sensenig, E; Andreozzi, J; Oliva, J; Rich, L; Constine, L; Becker, M; Phillips, G; Liesveld, J; Fisher, RI; Bernstein, SH; Friedberg, JW. "Late relapses followoing high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin Lymphoma (HL) in the ABVD therapeutic era." Biol Blood Marrow Transplant.. 2011; . |
2010 May 1
Biswas T, Dhakal S, Chen R, Hyrien O, Bernstein S, Friedberg JW, Fisher RI, Liesveld J, Phillips G, Constine LS. "Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era." International journal of radiation oncology, biology, physics. 2010 May 1; 77(1):79-85. Epub 2009 Aug 03. |
2010 Mar 11
Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, Wang SA. "Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification." Blood. 2010 Mar 11; 115(10):1985-92. Epub 2009 Dec 29. |
